Matthew Schiller
Corporate Officer/Principal chez NEXIMMUNE, INC.
Profil
Matthew Schiller is currently the Head of Business Development at NexImmune, Inc. Prior to this, he worked as the Director of Global Licensing & Business Development at EMD Serono, Inc. from 2015 to 2021.
He also served as the Senior Director of Business Development at Critical Therapeutics, Inc. and as the Vice President of Corporate Development at Ensemble Therapeutics Corp.
Mr. Schiller completed his undergraduate degree at the University of South Florida.
Postes actifs de Matthew Schiller
| Sociétés | Poste | Début |
|---|---|---|
| NEXIMMUNE, INC. | Corporate Officer/Principal | 14/07/2021 |
Anciens postes connus de Matthew Schiller
| Sociétés | Poste | Fin |
|---|---|---|
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01/07/2021 |
| Critical Therapeutics, Inc. | Corporate Officer/Principal | - |
Ensemble Therapeutics Corp.
 Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Ensemble Therapeutics Corp. develops novel classes of therapeutics and bioassays for research and diagnostics. The firm focuses on the discovery and development of breakthrough small molecule therapies for patients with cancer and other serious diseases. The company was founded by Douglas G. Cole, Noubar B. Afeyan and David R. Liu in 2004 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formation de Matthew Schiller
| University of South Florida | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NEXIMMUNE, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Critical Therapeutics, Inc. | Health Technology |
Ensemble Therapeutics Corp.
Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Ensemble Therapeutics Corp. develops novel classes of therapeutics and bioassays for research and diagnostics. The firm focuses on the discovery and development of breakthrough small molecule therapies for patients with cancer and other serious diseases. The company was founded by Douglas G. Cole, Noubar B. Afeyan and David R. Liu in 2004 and is headquartered in Cambridge, MA. | Process Industries |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
